Log in  First Connection?

Atopic DermatitisArchives

Innovation in pediatric atopic dermatitis care: examining emerging topical treatment options

 Published on 16/03/2026 |  Original article (Full-text)  | Christina McGee et al. | Expert Review of Clinical Pharmacology 2026; aop:10.1080/17512433.2026.2641800

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus, eczematous lesions, and a relapsing course. The pathophysiology of atopic dermatitis involves an interplay of skin barrier dysfunction, immune dysregulation, genetic predisposition, environmental triggers, and alterations...

Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina

 Published on 09/03/2026 |  Original article (Full-text)  | Natalia Espinola et al. | Expert Review of Pharmacoeconomics & Outcomes Research 2025; 25(1): 101-11

Our study assessed the budget impact and cost per responder of upadacitinib15mg and 30 mg for moderate to severe atopic dermatitis (MS-AD) treatment from social security and private health sector perspective in Argentina. A budget impact model was adapted to depict clinical and economic aspects...

Hidden bronchial obstruction in atopic dermatitis: just like wheezy infants

 Published on 02/03/2026 |  Original article (Full-text)  | Zeynep Gulec Koksal MD et al. | Journal of Asthma 2026; aop:10.1080/02770903.2026.2633353

Atopic dermatitis (AD) is frequently associated with respiratory comorbidities, yet data on pulmonary function in infancy remain scarce. This study aimed to evaluate pulmonary function in infants with AD using tidal breath analysis (TBA) and to compare these findings with those of wheezy infants and...

Washed microbiota transplantation relieves atopic dermatitis via gut–skin microbiome rebalancing

 Published on 23/02/2026 |  Original article (Full-text)  | Deng Wanying et al. | BMC Microbiology 2026; 26(1): 149

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease marked by pruritus, xerosis, erythema, and eczematous lesions, often with an atopic . Its global prevalence is rising, affecting up to 20% of children and 5% of adults [1, 2]. Beyond persistent itching and skin damage, AD impairs...

Atopic dermatitis and psychological disorders in children and adolescents: a systematic review on comorbidities and mechanism

 Published on 16/02/2026 |  Original article (Full-text)  | Zhu Zimo et al. | BMC Psychiatry 2026; 26(1): 154

Atopic dermatitis (AD) is a chronic inflammatory skin disorder with an increasing global disease burden [1]. Worldwide, it affects 15–20% of children and up to 10% of adults [2]. As a component of the atopic syndrome, AD is frequently associated with respiratory and gastrointestinal comorbidities...